Tennessee § 63-10-314 Promulgation of rules regarding oversight of facilities that manufacture, warehouse, and distribute medical devices

Tennessee Statutes

§ 63-10-314 — Promulgation of rules regarding oversight of facilities that manufacture, warehouse, and distribute medical devices

Tennessee § 63-10-314

Title63

This text of Tennessee § 63-10-314 (Promulgation of rules regarding oversight of facilities that manufacture, warehouse, and distribute medical devices) is published on Counsel Stack Legal Research, covering Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tenn. Code Ann. § 63-10-314 (2026).

Text

(a)The board shall promulgate rules regarding the board's oversight of facilities that manufacture, warehouse, and distribute medical devices. The rules promulgated under this subsection (a) must include the formation of an advisory committee, in accordance with § 4-5-205 , composed of medical device industry representatives and a representative of the department of economic and community development.

(b)The rules promulgated pursuant to this section must be reviewed by the advisory committee every three (3) years to review the advancements of new medical device technologies.

(c)The rules must be promulgated in accordance with the Uniform Administrative Procedures Act, compiled in title 4, chapter 5.

Free access — add to your briefcase to read the full text and ask questions with AI

(a) The board shall promulgate rules regarding the board's oversight of facilities that manufacture, warehouse, and distribute medical devices. The rules promulgated under this subsection (a) must include the formation of an advisory committee, in accordance with § 4-5-205 , composed of medical device industry representatives and a representative of the department of economic and community development. (b) The rules promulgated pursuant to this section must be reviewed by the advisory committee every three (3) years to review the advancements of new medical device technologies. (c) The rules must be promulgated in accordance with the Uniform Administrative Procedures Act, compiled in title 4, chapter 5.